NEW YORK (GenomeWeb News) - Galapagos said today that it has entered an agreement to buy drug-discovery firm ProSkelia for €12.5 million ($16.4 million) in stock.
 
Galapagos also said it has raised €31 million ($40.7 million) in financing through the private placement of new shares to institutional investors in Europe and the US. 
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

In Nature this week: ash dieback disease fungal genome, and more.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.